Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder
Status:
Terminated
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial was to determine whether a 36-ingredient micronutrient supplement
(primarily vitamins and minerals) is beneficial for the treatment of bipolar disorder, when
studied under randomized and fully blinded conditions and compared to a placebo. The
supplement is referred to as MCN36, because it contains 36 nutrients. Based on the
preliminary research on this supplement, it is hypothesized that patients who take MCN36 for
8 weeks will experience improved mood stability relative to those who take the placebo. All
participants must live EITHER in the vicinity of Calgary, Alberta, Canada, OR in the area of
San Diego, California.